Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

Clinical trial NCT00184548 · TERMINATED

Trial details

NCT number: NCT00184548
Sponsor: Novo Nordisk A/S
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Trauma

Start date: 2005-10-01
Primary completion: 2008-09-01
Enrollment: 554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.